Table 2.
Clinical Characteristics Prior to Therapy and at 2 Months Post–Initiation of Therapy for the Drug-Sensitive and Drug-Resistant Tuberculosis Cohorts
| Characteristic | Day 0 (Pretreatment) | Month 2 (Post–Initiation of Therapy) | ||||
|---|---|---|---|---|---|---|
| DS-TB (n = 31) | DR-TB (n = 23) | P Value | DS-TB (n = 21–24)a | DR-TB (n = 19–21)a | P Value | |
| Dyspnea | 18 (58.1) | 20 (87.0) | .046 | 12 (50.0) | 7 (35.0) | .487 |
| Cough | 31 (100.0) | 22 (95.7) | .880 | 19 (79.2) | 13 (65.0) | .477 |
| Fever | 10 (32.3) | 5 (22.7) | .653 | 0 (0.0) | 0 (0.0) | NA |
| Blood-tinged sputum | 0 (0.0) | 2 (8.7) | .345 | 1 (4.2) | 1 (5.3) | 1.00 |
| Frank hemoptysis | 0 (0.0) | 0 (0.0) | NA | 0 (0.0) | 0 (0.0) | NA |
| Pleuritic chest pain | 10 (32.3) | 13 (56.5) | .132 | 10 (41.7) | 10 (50.0) | .804 |
| BMI, kg/m2, median (IQR) | 19.0 (17.3–21.0) | 17.9 (17.0–19.6) | .407 | 19.6 (18.4–21.9) | 18.7 (17.4–20.9) | .289 |
| Pulse oximetry, %, median (IQR) | 97.00 (95.2–98.0) | 97.00 (96.0–98.5) | .386 | 98.0 (96.0–98.0) | 99.0 (97.8–99.0) | .003 |
P-values less than 0.05 have been bolded. Data are presented as No. (%) unless otherwise indicated.
Abbreviations: BMI, body mass index; DR-TB, drug-resistant tuberculosis; DS-TB, drug-sensitive tuberculosis; IQR, interquartile range; NA, not applicable; USD, United States dollars.
aNot all participant characteristics were recorded for all participants at month 2, resulting in the variable n values.